SFCM
OCUL icon

Seven Fleet Capital Management’s Ocular Therapeutix OCUL Stock Holding History

Seven Fleet Capital Management’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$265K Buy
31,296
+14,196
+83% +$135K 0.08% 99
2025
Q4 		$208K Buy
+17,100
New +$208K 0.14% 65

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Seven Fleet Capital Management's OCUL Position: Q1 2026 in Review

Seven Fleet Capital Management increased its Ocular Therapeutix (OCUL) stake by 83% in Q1 2026, buying an estimated $135K and bringing the position to 31,296 shares worth $265K. The position accounts for 0.08% of the portfolio, ranked #99.

Seven Fleet Capital Management first reported a position in OCUL in Q4 2025 and has held it in 2 quarters since. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • Seven Fleet Capital Management held 31,296 shares of Ocular Therapeutix worth $265K as of Q1 2026.
  • Seven Fleet Capital Management bought 14,196 Ocular Therapeutix shares in Q1 2026, an estimated $135K.
  • Ocular Therapeutix made up 0.08% of Seven Fleet Capital Management's portfolio in Q1 2026, its #99 holding.
  • Seven Fleet Capital Management first reported a position in Ocular Therapeutix in Q4 2025 and has held it in 2 quarters since.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.